Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 100,781 | 100,781 | 0 | $29.70M | $32.47M | 20.34% | +$2.77M |
| Protara Therapeutics, Inc.(TARA) | 2,834,652 | 2,834,652 | 0 | $15.11M | $14.77M | 9.25% | -$340.2K |
| Sutro Biopharma, Inc.(STRO) | 312,000 | 512,160 | +200,160 | $3.61M | $12.76M | 7.99% | +$9.15M |
| Evommune, Inc.(EVMN) | 506,754 | 446,255 | -60,499 | $8.68M | $10.26M | 6.43% | +$1.58M |
| MapLight Therapeutics, Inc.(MPLT) | 522,305 | 492,893 | -29,412 | $9.17M | $10.02M | 6.28% | +$846.2K |
| Tenax Therapeutics, Inc.(TENX) | 83,333 | 583,333 | +500,000 | $1.02M | $9.33M | 5.84% | +$8.31M |
| ABIVAX Société AnonymeADS(ABVX) | 67,000 | 77,000 | +10,000 | $9.04M | $8.57M | 5.37% | -$461.3K |
| Heron Therapeutics, Inc.(HRTX) | 8,753,290 | 8,753,290 | 0 | $11.38M | $7.00M | 4.39% | -$4.38M |
| Immix Biopharma, Inc.(IMMX) | 35,000 | 740,000 | +705,000 | $183.1K | $6.74M | 4.22% | +$6.56M |
| Esperion Therapeutics Inc Ne | 1,210,000 | 1,720,000 | +510,000 | $4.48M | $4.71M | 2.95% | +$235.8K |
| Edesa Biotech, Inc.(EDSA) | 687,500 | 827,500 | +140,000 | $976.3K | $4.33M | 2.71% | +$3.35M |
| Anteris Technologies Global Corp.(AVR) | 0 | 700,000 | +700,000 | $0 | $3.88M | 2.43% | +$3.88M |
| InspireMD, Inc.(NSPR) | 2,143,698 | 2,099,652 | -44,046 | $3.82M | $3.42M | 2.14% | -$393.3K |
| Xencor, Inc.(XNCR) | 0 | 250,000 | +250,000 | $0 | $3.02M | 1.89% | +$3.02M |
| Avalo Therapeutics, Inc.(AVTX) | 263,642 | 185,122 | -78,520 | $4.79M | $2.76M | 1.73% | -$2.02M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 352,000 | 352,000 | 0 | $2.66M | $2.55M | 1.60% | -$109.1K |
| CytomX Therapeutics, Inc.(CTMX) | 80,000 | 540,000 | +460,000 | $340.8K | $2.54M | 1.59% | +$2.20M |
| Verrica Pharmaceuticals Inc.(VRCA) | 471,559 | 471,559 | 0 | $3.92M | $2.49M | 1.56% | -$1.42M |
| Jasper Therapeutics, Inc.(JSPR) | 2,668,395 | 2,668,395 | 0 | $4.88M | $2.34M | 1.46% | -$2.55M |
| Rezolute, Inc.(RZLT) | 750,000 | 750,000 | 0 | $1.77M | $2.29M | 1.43% | +$517.5K |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 102,000 | +102,000 | $0 | $2.05M | 1.28% | +$2.05M |
| Profound Medical Corp.(PROF) | 285,710 | 285,710 | 0 | $2.25M | $1.85M | 1.16% | -$397.1K |
| Viridian Therapeutics, Inc.(VRDN) | 86,500 | 91,123 | +4,623 | $2.69M | $1.78M | 1.12% | -$909.5K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 0 | 294,643 | +294,643 | $0 | $1.05M | 0.66% | +$1.05M |
| Kazia Therapeutics LimitedADS(KZIA) | 300,000 | 135,315 | -164,685 | $2.07M | $1.01M | 0.63% | -$1.06M |
| Nasus Pharma Ltd.(NSRX) | 0 | 359,390 | +359,390 | $0 | $797.8K | 0.50% | +$797.8K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 0 | 84,849 | +84,849 | $0 | $560.0K | 0.35% | +$560.0K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 6,500 | 6,500 | 0 | $431.5K | $407.6K | 0.26% | -$24.0K |
| Protagonist Therapeutics Inc | 3,700 | 3,700 | 0 | $323.2K | $390.0K | 0.24% | +$66.8K |
| Ovid Therapeutics Inc.(OVID) | 160,000 | 160,000 | 0 | $260.8K | $355.2K | 0.22% | +$94.4K |
| Mineralys Therapeutics, Inc.(MLYS) | 151,000 | 11,000 | -140,000 | $5.48M | $298.0K | 0.19% | -$5.18M |
| Context Therapeutics Inc.(CNTX) | 100,000 | 100,000 | 0 | $147.0K | $262.0K | 0.16% | +$115.0K |
| Nurix Therapeutics, Inc.(NRIX) | 16,000 | 16,000 | 0 | $303.5K | $248.0K | 0.16% | -$55.5K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 13,000 | 26,000 | +13,000 | $105.8K | $244.1K | 0.15% | +$138.3K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 130,000 | 10,000 | -120,000 | $2.73M | $233.6K | 0.15% | -$2.50M |
| Precision BioSciences, Inc.(DTIL) | 20,000 | 40,000 | +20,000 | $83.2K | $220.0K | 0.14% | +$136.8K |
| Immunome, Inc.(IMNM) | 10,000 | 10,000 | 0 | $214.8K | $218.7K | 0.14% | +$3.9K |
| Design Therapeutics, Inc.(DSGN) | 20,000 | 20,000 | 0 | $187.6K | $212.8K | 0.13% | +$25.2K |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 25,000 | +25,000 | $0 | $161.0K | 0.10% | +$161.0K |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 80,000 | +80,000 | $0 | $156.0K | 0.10% | +$156.0K |
| Replimune Group, Inc.(REPL) | 15,000 | 20,000 | +5,000 | $145.8K | $153.0K | 0.10% | +$7.2K |
| Larimar Therapeutics, Inc.(LRMR) | 33,000 | 33,000 | 0 | $125.7K | $148.5K | 0.09% | +$22.8K |
| Xilio Therapeutics, Inc.(XLO) | 0 | 14,285 | +14,285 | $0 | $120.1K | 0.08% | +$120.1K |
| Kalaris Therapeutics, Inc.(KLRS) | 0 | 18,000 | +18,000 | $0 | $103.9K | 0.07% | +$103.9K |
| PMV Pharmaceuticals, Inc.(PMVP) | 35,000 | 73,000 | +38,000 | $43.8K | $90.5K | 0.06% | +$46.8K |
| MacroGenics, Inc.(MGNX) | 0 | 30,000 | +30,000 | $0 | $86.7K | 0.05% | +$86.7K |
| Karyopharm Therapeutics Inc.(KPTI) | 0 | 15,000 | +15,000 | $0 | $83.5K | 0.05% | +$83.5K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 45,000 | 45,000 | 0 | $90.9K | $72.9K | 0.05% | -$18.0K |
| Gossamer Bio, Inc.(GOSS) | 70,000 | 70,000 | 0 | $217.0K | $23.0K | 0.01% | -$194.0K |
| Cidara Therapeutics Inc | 108,404 | 0 | -108,404 | $23.95M | $0 | — | -$23.95M |
| Lantheus Holdings, Inc.(LNTH) | 74,687 | 0 | -74,687 | $4.97M | $0 | — | -$4.97M |
| Pyxis Oncology, Inc.(PYXS) | 40,000 | 0 | -40,000 | $46.0K | $0 | — | -$46.0K |
| Rapt Therapeutics Inc | 108,000 | 0 | -108,000 | $3.66M | $0 | — | -$3.66M |
| Terns Pharmaceuticals Inc | 70,000 | 0 | -70,000 | $2.83M | $0 | — | -$2.83M |
| Trevi Therapeutics, Inc.(TRVI) | 205,000 | 0 | -205,000 | $2.57M | $0 | — | -$2.57M |
| Ventyx Biosciences Inc | 40,000 | 0 | -40,000 | $361.2K | $0 | — | -$361.2K |
| Xilio Therapeutics, Inc.(XLO) | 170,000 | 0 | -170,000 | $108.8K | $0 | — | -$108.8K |